Cover Image
Market Research Report

Global Neurostimulation Market by Product Type (Implantable and Non-implantable), By Indication (Chronic pain, Movement disorders, Epilepsy and others), By End User, and by Geography - Opportunities & Forecast, 2018-2025

Published by GMI Research Product code 836187
Published Content info 129 Pages
Delivery time: 1-2 business days
Price
Back to Top
Global Neurostimulation Market by Product Type (Implantable and Non-implantable), By Indication (Chronic pain, Movement disorders, Epilepsy and others), By End User, and by Geography - Opportunities & Forecast, 2018-2025
Published: May 8, 2019 Content info: 129 Pages
Description

Title:
Global Neurostimulation Market
by Product Type (Implantable {Deep Brain Stimulators, Sacral Nerve Stimulator, Spinal Cord Stimulators, Vagus Nerve Stimulators and Others} and Non-implantable {Transcranial Magnetic Stimulation (TMS) and Transcutaneous Electrical Nerve Stimulation (TENS)}), By Indication (Chronic pain, Movement disorders, Epilepsy and others), By End User (Hospitals, Ambulatory Surgical Centers and Specialty Clinics), and by Geography - Opportunities & Forecast, 2018-2025.

The global neurostimulation market was valued at USD 5,716.5 million in 2017, and is projected to reach USD 14,476.4 million by the end of 2025, growing at a CAGR of 12.6% during 2018-2025.

The key factors bolstering the market growth are increasing prevalence of neurological disorders, such as epilepsy, Parkinson's disease, dystonia, depression, migraine, and chronic pain. In addition, strong clinical needs, expanding research activities and advances in neural stimulation technology in combination with a deeper understanding of the nervous system are also expected to aid the market growth.

Based on product type, implantable spinal cord stimulators segment is anticipated to lead the market during 2018-2025

Implantable spinal cord stimulators product type segment is expected to dominate the market during the forecast period due to an increase in clinical trials for the treatment of new indications. Moreover, the adoption of spinal cord stimulators is high as compared to conventional treatments as spinal cord stimulation procedure is minimally invasive, provides quicker recovery and is cost-effective.

The chronic pain by indication segment held the largest share in 2017 in the market, and is predicted to exhibit a significant growth rate during the forecast period owing to rising patients' emphasis on timely and effective pain management and increase in prevalence of chronic pain disorder, globally. For instance, according to the American Academy of Pain Medicine, in 2011, more than 100.0 million people were affected by the chronic pain in the United States. Also, extensive research and development activities and the introduction of advanced neurostimulation products are predicted to aid the market growth in the coming years.

Players, such as Boston Scientific Corporation, Medtronic plc, Cyberonics, Inc., and Nevro Corp are focusing on R&D activities to expand their product portfolio.

Based on geography, North America held the largest share in the market in 2017 due to the presence of well-developed healthcare infrastructure, growing awareness among individuals about neurostimulation, and increasing adoption of neurostimulation procedures in the region. Asia-Pacific is the fastest growing region in global neurostimulation market and is projected to grow at CAGR of 14.2% during 2018-2025 due to the presence of a large patient pool, rising disposable income, etc.

Various notable players operating in the market include Boston Scientific Corporation, Medtronic plc, Cyberonics, Inc., Nevro Corp, NeuroPace, Inc., DePuy Synthes, NeuroSigma, Inc., Synapse Biomedical Inc., MED-EL., among others.

The global neurostimulation market has been segmented on the basis of product type, indication, end user, and key geographies. Based on the product type, global neurostimulation market has been segmented into implantable and non-implantable. Wherein, the implantable segment includes deep brain stimulators, sacral nerve stimulators, spinal cord stimulators, vagus nerve stimulators, and others and non-implantable segment includes transcranial magnetic stimulation (TMS) and transcutaneous electrical nerve stimulation (TENS). Based on indication type, global neurostimulation market has been segmented into chronic pain, movement disorders, epilepsy, and others. Based on end user, the market has been segmented into hospitals, ambulatory surgical centers, and specialty clinics.

The research report “global neurostimulation market” provides in-depth analysis of neurostimulation market, globally, based on product type, indication, end user and major geographies for the forecast period from 2018 to 2025. The report highlights the major market drivers fueling the growth as well as challenges faced by the market participants. The research report provides market size and forecast for neurostimulation market. The report also analyzes the competitive landscape, major players and their strategies in 2018. The competitive landscape section of the report captures and highlights the recent developments in the market.

Key questions answered in this research report:

  • 1. At what pace is neurostimulation market growing, globally? What will be the growth trend in future?
  • 2. What are the key drivers and restraints in the current market? What will be the impact of drivers and restraints over the coming years?
  • 3. What are the regional revenue and forecast breakdowns? Which are the major regional revenue pockets for growth in the neurostimulation market?
  • 4. What are the various application areas and how they are poised to grow?
Table of Contents
Product Code: HM27A-00-1118

Table of Contents

1. Executive Summary

2. Introduction

  • 2.1. Study Objectives
  • 2.2. Scope of the Study - Markets Covered
  • 2.3. Scope of the Study - Geographical Coverage
  • 2.4. Study Years & Currency
  • 2.5. Global Neurostimulation Market Stakeholders
  • 2.6. GMI Research's Approach & Methodology
  • 2.7. Key Questions this study will answer

3. Global Healthcare IoT Market- Overview

  • 3.1. Introduction
  • 3.2. Market Segmentation Product Type
  • 3.3. Global Healthcare Outlook
  • 3.4. Drivers
  • 3.5. Restraints
  • 3.6. Trends

4. Global Neurostimulation Market

5. Global Neurostimulation Market - By Product Type

  • 5.1. Global Neurostimulation Market, By Deep Brain Stimulators
  • 5.2. Global Neurostimulation Market, By Sacral Nerve Stimulator
  • 5.3. Global Neurostimulation Market, By Spinal Cord Stimulators
  • 5.4. Global Neurostimulation Market, By Vagus Nerve Stimulators
  • 5.5. Global Neurostimulation Market, By Others
  • 5.6. Global Neurostimulation Market, By Transcranial Magnetic Stimulation (TMS)
  • 5.7. Global Neurostimulation Market, By Transcutaneous Electrical Nerve stimulation (TENS)

6. Global Neurostimulation Market - By Indication55

  • 6.1. Global Neurostimulation Market, By Chronic pain
  • 6.2. Global Neurostimulation Market, By Movement disorders
  • 6.3. Global Neurostimulation Market, By Epilepsy
  • 6.4. Global Neurostimulation Market, By Others

7. Global Neurostimulation Market - By End User

  • 7.1. Global Neurostimulation Market, By Ambulatory Surgical Centers
  • 7.2. Global Neurostimulation Market, By Clinics

8. Global Neurostimulation Market - By Geography

  • 8.1. North America Neurostimulation Market
  • 8.2. Europe Neurostimulation Market
  • 8.3. Asia-Pacific Neurostimulation Market
  • 8.4. Rest of the World Neurostimulation Market

9. Competitive Landscape

  • 9.1. Porter's Five Forces Analysis

10. Company Profiles

  • 10.1. Boston Scientific Corporation
  • 10.2. DePuy Synthes
  • 10.3. Cyberonics Inc.
  • 10.4. Medtronic Plc
  • 10.5. Medtronic Plc
  • 10.6. Neuronetics, Inc.
  • 10.7. NeuroSigma, Inc.
  • 10.8. Nevro Corporation
  • 10.9. Penumbra, Inc.
  • 10.10. Synapse Biomedical Inc.

11. About GMI Research

List of Figures

  • Figure 1: Global Neurostimulation Market Revenue by Region, 20179
  • Figure 2: Global Neurostimulation Market Revenue Forecast (2018-2025)9
  • Figure 3: Global Neurostimulation Market Revenue Forecast (2018-2025), by Product Type9
  • Figure 4: Global Neurostimulation Market, Market Revenue share, by Product Type, 20179
  • Figure 5: Global Neurostimulation Market: Segment Attractiveness by End User, Global Market 2017--2025 10
  • Figure 6: Scope of the Study -- Markets Covered16
  • Figure 7: Scope of the Study -- Segmentation by Region17
  • Figure 8: Global Neurostimulation Market, Study Years18
  • Figure 9: Global Neurostimulation Market Stakeholders19
  • Figure 10: Research Methodology20
  • Figure 11: Key Questions this Study will Answer21
  • Figure 12: Types of Neurostimulation Market24
  • Figure 13: Healthcare Expenditure % of GDP by Countries25
  • Figure 14: Global Neurostimulation Market Drivers26
  • Figure 15: Global Neurostimulation Market Drivers-Impact29
  • Figure 16: Global Neurostimulation Market Restraints30
  • Figure 17: Global Neurostimulation Market Restraints - Impact32
  • Figure 18: Global Neurostimulation Market Trends33
  • Figure 19: Global Neurostimulation Market, Revenue Forecast 2018--2025 (USD Million)37
  • Figure 20: Global Neurostimulation Market, by product Type, Revenue%, 201740
  • Figure 21: Global Neurostimulation Market, by product Type, Revenue%, 202540
  • Figure 22: Global Neurostimulation Market by Deep Brain Stimulators, Revenue Forecast 2018--2025 (USD Million)41
  • Figure 23: Global Neurostimulation Market by Sacral Nerve Stimulator, Revenue Forecast 2018--2025 (USD Million)43
  • Figure 24: Global Neurostimulation Market Spinal Cord Stimulators, Revenue Forecast 2018--2025 (USD Million)45
  • Figure 25: Global Neurostimulation Market by Vagus Nerve Stimulators, Revenue Forecast 2018--2025 (USD Million)47
  • Figure 26: Global Neurostimulation Market by Others, Revenue Forecast 2018--2025 (USD Million)49
  • Figure 27: Global Neurostimulation Market by Transcranial Magnetic Stimulation (TMS), Revenue Forecast 2018--2025 (USD Million)51
  • Figure 28: Global Neurostimulation Market by Transcutaneous Electrical Nerve stimulation (TENS), Revenue Forecast 2018--2025 (USD Million)53
  • Figure 29: Global Neurostimulation Market, by Indication, Revenue% Share, 201756
  • Figure 30: Global Neurostimulation Market, by Indication, Revenue% Share, 2025 56
  • Figure 31: Global Neurostimulation Market By Chronic pain, Revenue Forecast 2018--2025 (USD Million)57
  • Figure 32: Global Neurostimulation Market By Movement disorders, Revenue Forecast 2018--2025 (USD Million)59
  • Figure 33: Global Neurostimulation Market By Epilepsy, Revenue Forecast 2018--2025 (USD Million)61
  • Figure 34: Global Neurostimulation Market By Others, Revenue Forecast 2018--2025 (USD Million)63
  • Figure 35: Global Neurostimulation Market, by End User, Revenue% Share, 201766
  • Figure 36: Global Neurostimulation Market, by End User, Revenue% Share, 2025 66
  • Figure 37: Global Neurostimulation Market By Ambulatory Surgical Centers, Revenue Forecast 2018--2025 (USD Million)67
  • Figure 38: Global Neurostimulation Market By Clinics, Revenue Forecast 2018--2025 (USD Million)69
  • Figure 39: Global Neurostimulation Market, by Geography, Revenue% Share, 201772
  • Figure 40: Global Neurostimulation Market, by Geography, Revenue% Share, 201772
  • Figure 41: North America Neurostimulation Market, Revenue Forecast 2018--2025 (USD Million)73
  • Figure 42: Europe Neurostimulation Market, Revenue Forecast 2018--2025 (USD Million)75
  • Figure 43: Asia-Pacific Neurostimulation Market, Revenue Forecast 2018--2025 (USD Million)77
  • Figure 44: Rest of the World Neurostimulation Market, Revenue Forecast 2018--2025 (USD Million)79
  • Figure 45: Porter's Five Forces Analysis82
  • Figure 46: Boston Scientific Corporation Business Segments88
  • Figure 47: Boston Scientific Corporation Revenue and Growth Rate (%), FY15-1789
  • Figure 48: Boston Scientific Corporation Revenue % Breakdown by Business Segment, FY15-1789
  • Figure 49: Boston Scientific Corporation Revenue % Breakdown by Geography, FY1789
  • Figure 50: Depuy Synthes Business Segments92
  • Figure 51: DePuy Synthes Revenue and Growth Rate (%), FY15-1793
  • Figure 52: Cyberonics Inc. Business Segments96
  • Figure 53: Cyberonics Inc. Revenue and Growth Rate (%), FY 2015-1797
  • Figure 54: Cyberonics Inc. Revenue % Breakdown by Business Segment, FY 2015-1797
  • Figure 55: Cyberonics Inc. Revenue % Breakdown by Geography, FY 201797
  • Figure 56: Medtronic Plc's Business Segments100
  • Figure 57: Medtronic plc Revenue and Growth Rate (%), FY 2015-17101
  • Figure 58: Medtronic plc Revenue % Breakdown by Business Segment, FY 2015-17101
  • Figure 59: Medtronic plc Revenue % Breakdown by Geography, FY 2017101
  • Figure 60: Neuronetics,Inc. Business Segments104
  • Figure 61: Neuronetics,Inc. Revenue and Growth Rate (%), FY15-17105
  • Figure 62: Neuronetics,Inc. Revenue % Breakdown by Business Segment, FY15-17105
  • Figure 63: Neuronetics,Inc. Revenue % Breakdown by Geography, FY17105
  • Figure 64: NeuroPace, Inc. Business Segments108
  • Figure 65: NeuroSigma Inc. Business Segments111
  • Figure 66: Nevro Corporation Business Segments114
  • Figure 67: Nevro Corporation Revenue and Growth Rate (%), FY 2015-17115
  • Figure 68: Nevro Corporation Revenue % Breakdown by Geography, FY 2017115
  • Figure 69: Penumbra Inc. Business Segments118
  • Figure 70: Penumbra, Inc. Revenue and Growth Rate (%), FY 2015-17119
  • Figure 71: Penumbra, Inc. Revenue% Breakdown by Business Segment, FY 2015-17119
  • Figure 72: Penumbra, Inc. Revenue% Breakdown by Geography, FY 2017119
  • Figure 73: Synapse Biomedical Inc. Business Segments122

List of Tables

  • Table 1: Boston Scientific Corporation Recent Developments90
  • Table 2: DePuy Synthes Recent Developments94
  • Table 3: Cyberonics Inc. Recent Developments98
  • Table 4: Medtronic Plc Recent Developments102
  • Table 5: Neuronetics, Inc. Recent Developments106
  • Table 6: NeuroPace, Inc. Recent Developments109
  • Table 7: NeuroSigma Inc. Recent Developments112
  • Table 8: Nevro Corporation Recent Developments116
  • Table 9: Penumbra, Inc. Recent Developments120
  • Table 10: Synapse Biomedical Inc. Recent Developments123
Back to Top